PD-L1 Epitope Mapping Peptide Array
The PD-L1 (Programmed cell death 1 ligand 1/CD274/B7-H1)Â Epitope Mapping Peptide Array is a semi-quantitative array displaying 261 synthesized peptides representing the full-length PD-L1. It is suitable for antibody epitope mapping and detection of IgG, IgA, IgM, IgE, etc. in serum, plasma, and many other liquid sample types.
For a service quote, please fill out the Epitope Mapping Array Quote Request Form.
Product Description
Specifications
Size | 4 Sample Kit, 8 Sample Kit, 16 Sample Kit |
---|---|
Species | Human |
Accession Number | Q9NZQ7 |
Protein Name / Synonyms | PD-L1 / Programmed cell death 1 ligand 1 / CD274 / B7-H1 |
Quantitative/Semi-Quantitative | Semi-Quantitative |
Number of Targets Detected | 261 |
Compatible Sample Types | Plasma, Serum, Ascites, Hybridoma cell culture medium, Purified antibodies, Purified protein, DNA Aptamers, Other fluids |
Solid Support | Glass Slide |
Method Of Detection | Fluorescence Laser Scanner |
Research Area | Antibody Drug Development, Drug Antibody (DA) Detection |
Estimated Lead Time | 4-6 weeks |
Shipping Type | Blue ice |
Storage | -20°C |
Amazon Gift Cards!
$5 Amazon gift card in every kit box purchased.
1. FTVTVPKDLYVV | 2. TVTVPKDLYVVE | 3. VTVPKDLYVVEY | 4. TVPKDLYVVEYG |
5. VPKDLYVVEYGS | 6. PKDLYVVEYGSN | 7. KDLYVVEYGSNM | 8. DLYVVEYGSNMT |
9. LYVVEYGSNMTI | 10. YVVEYGSNMTIE | 11. VVEYGSNMTIEC | 12. VEYGSNMTIECK |
13. EYGSNMTIECKF | 14. YGSNMTIECKFP | 15. GSNMTIECKFPV | 16. SNMTIECKFPVE |
17. NMTIECKFPVEK | 18. MTIECKFPVEKQ | 19. TIECKFPVEKQL | 20. IECKFPVEKQLD |
21. ECKFPVEKQLDL | 22. CKFPVEKQLDLA | 23. KFPVEKQLDLAA | 24. FPVEKQLDLAAL |
25. PVEKQLDLAALI | 26. VEKQLDLAALIV | 27. EKQLDLAALIVY | 28. KQLDLAALIVYW |
29. QLDLAALIVYWE | 30. LDLAALIVYWEM | 31. DLAALIVYWEME | 32. LAALIVYWEMED |
33. AALIVYWEMEDK | 34. ALIVYWEMEDKN | 35. LIVYWEMEDKNI | 36. IVYWEMEDKNII |
37. VYWEMEDKNIIQ | 38. YWEMEDKNIIQF | 39. WEMEDKNIIQFV | 40. EMEDKNIIQFVH |
41. MEDKNIIQFVHG | 42. EDKNIIQFVHGE | 43. DKNIIQFVHGEE | 44. KNIIQFVHGEED |
45. NIIQFVHGEEDL | 46. IIQFVHGEEDLK | 47. IQFVHGEEDLKV | 48. QFVHGEEDLKVQ |
49. FVHGEEDLKVQH | 50. VHGEEDLKVQHS | 51. HGEEDLKVQHSS | 52. GEEDLKVQHSSY |
53. EEDLKVQHSSYR | 54. EDLKVQHSSYRQ | 55. DLKVQHSSYRQR | 56. LKVQHSSYRQRA |
57. KVQHSSYRQRAR | 58. VQHSSYRQRARL | 59. QHSSYRQRARLL | 60. HSSYRQRARLLK |
61. SSYRQRARLLKD | 62. SYRQRARLLKDQ | 63. YRQRARLLKDQL | 64. RQRARLLKDQLS |
65. QRARLLKDQLSL | 66. RARLLKDQLSLG | 67. ARLLKDQLSLGN | 68. RLLKDQLSLGNA |
69. LLKDQLSLGNAA | 70. LKDQLSLGNAAL | 71. KDQLSLGNAALQ | 72. DQLSLGNAALQI |
73. QLSLGNAALQIT | 74. LSLGNAALQITD | 75. SLGNAALQITDV | 76. LGNAALQITDVK |
77. GNAALQITDVKL | 78. NAALQITDVKLQ | 79. AALQITDVKLQD | 80. ALQITDVKLQDA |
81. LQITDVKLQDAG | 82. QITDVKLQDAGV | 83. ITDVKLQDAGVY | 84. TDVKLQDAGVYR |
85. DVKLQDAGVYRC | 86. VKLQDAGVYRCM | 87. KLQDAGVYRCMI | 88. LQDAGVYRCMIS |
89. QDAGVYRCMISY | 90. DAGVYRCMISYG | 91. AGVYRCMISYGG | 92. GVYRCMISYGGA |
93. VYRCMISYGGAD | 94. YRCMISYGGADY | 95. RCMISYGGADYK | 96. CMISYGGADYKR |
97. MISYGGADYKRI | 98. ISYGGADYKRIT | 99. SYGGADYKRITV | 100. YGGADYKRITVK |
101. GGADYKRITVKV | 102. GADYKRITVKVN | 103. ADYKRITVKVNA | 104. DYKRITVKVNAP |
105. YKRITVKVNAPY | 106. KRITVKVNAPYN | 107. RITVKVNAPYNK | 108. ITVKVNAPYNKI |
109. TVKVNAPYNKIN | 110. VKVNAPYNKINQ | 111. KVNAPYNKINQR | 112. VNAPYNKINQRI |
113. NAPYNKINQRIL | 114. APYNKINQRILV | 115. PYNKINQRILVV | 116. YNKINQRILVVD |
117. NKINQRILVVDP | 118. KINQRILVVDPV | 119. INQRILVVDPVT | 120. NQRILVVDPVTS |
121. QRILVVDPVTSE | 122. RILVVDPVTSEH | 123. ILVVDPVTSEHE | 124. LVVDPVTSEHEL |
125. VVDPVTSEHELT | 126. VDPVTSEHELTC | 127. DPVTSEHELTCQ | 128. PVTSEHELTCQA |
129. VTSEHELTCQAE | 130. TSEHELTCQAEG | 131. SEHELTCQAEGY | 132. EHELTCQAEGYP |
133. HELTCQAEGYPK | 134. ELTCQAEGYPKA | 135. LTCQAEGYPKAE | 136. TCQAEGYPKAEV |
137. CQAEGYPKAEVI | 138. QAEGYPKAEVIW | 139. AEGYPKAEVIWT | 140. EGYPKAEVIWTS |
141. GYPKAEVIWTSS | 142. YPKAEVIWTSSD | 143. PKAEVIWTSSDH | 144. KAEVIWTSSDHQ |
145. AEVIWTSSDHQV | 146. EVIWTSSDHQVL | 147. VIWTSSDHQVLS | 148. IWTSSDHQVLSG |
149. WTSSDHQVLSGK | 150. TSSDHQVLSGKT | 151. SSDHQVLSGKTT | 152. SDHQVLSGKTTT |
153. DHQVLSGKTTTT | 154. HQVLSGKTTTTN | 155. QVLSGKTTTTNS | 156. VLSGKTTTTNSK |
157. LSGKTTTTNSKR | 158. SGKTTTTNSKRE | 159. GKTTTTNSKREE | 160. KTTTTNSKREEK |
161. TTTTNSKREEKL | 162. TTTNSKREEKLF | 163. TTNSKREEKLFN | 164. TNSKREEKLFNV |
165. NSKREEKLFNVT | 166. SKREEKLFNVTS | 167. KREEKLFNVTST | 168. REEKLFNVTSTL |
169. EEKLFNVTSTLR | 170. EKLFNVTSTLRI | 171. KLFNVTSTLRIN | 172. LFNVTSTLRINT |
173. FNVTSTLRINTT | 174. NVTSTLRINTTT | 175. VTSTLRINTTTN | 176. TSTLRINTTTNE |
177. STLRINTTTNEI | 178. TLRINTTTNEIF | 179. LRINTTTNEIFY | 180. RINTTTNEIFYC |
181. INTTTNEIFYCT | 182. NTTTNEIFYCTF | 183. TTTNEIFYCTFR | 184. TTNEIFYCTFRR |
185. TNEIFYCTFRRL | 186. NEIFYCTFRRLD | 187. EIFYCTFRRLDP | 188. IFYCTFRRLDPE |
189. FYCTFRRLDPEE | 190. YCTFRRLDPEEN | 191. CTFRRLDPEENH | 192. TFRRLDPEENHT |
193. FRRLDPEENHTA | 194. RRLDPEENHTAE | 195. RLDPEENHTAEL | 196. LDPEENHTAELV |
197. DPEENHTAELVI | 198. PEENHTAELVIP | 199. EENHTAELVIPE | 200. ENHTAELVIPEL |
201. NHTAELVIPELP | 202. HTAELVIPELPL | 203. TAELVIPELPLA | 204. AELVIPELPLAH |
205. ELVIPELPLAHP | 206. LVIPELPLAHPP | 207. VIPELPLAHPPN | 208. IPELPLAHPPNE |
209. PELPLAHPPNER | 210. ELPLAHPPNERT | 211. LPLAHPPNERTH | 212. PLAHPPNERTHL |
213. LAHPPNERTHLV | 214. AHPPNERTHLVI | 215. HPPNERTHLVIL | 216. PPNERTHLVILG |
217. PNERTHLVILGA | 218. NERTHLVILGAI | 219. ERTHLVILGAIL | 220. RTHLVILGAILL |
221. THLVILGAILLC | 222. HLVILGAILLCL | 223. LVILGAILLCLG | 224. VILGAILLCLGV |
225. ILGAILLCLGVA | 226. LGAILLCLGVAL | 227. GAILLCLGVALT | 228. AILLCLGVALTF |
229. ILLCLGVALTFI | 230. LLCLGVALTFIF | 231. LCLGVALTFIFR | 232. CLGVALTFIFRL |
233. LGVALTFIFRLR | 234. GVALTFIFRLRK | 235. VALTFIFRLRKG | 236. ALTFIFRLRKGR |
237. LTFIFRLRKGRM | 238. TFIFRLRKGRMM | 239. FIFRLRKGRMMD | 240. IFRLRKGRMMDV |
241. FRLRKGRMMDVK | 242. RLRKGRMMDVKK | 243. LRKGRMMDVKKC | 244. RKGRMMDVKKCG |
245. KGRMMDVKKCGI | 246. GRMMDVKKCGIQ | 247. RMMDVKKCGIQD | 248. MMDVKKCGIQDT |
249. MDVKKCGIQDTN | 250. DVKKCGIQDTNS | 251. VKKCGIQDTNSK | 252. KKCGIQDTNSKK |
253. KCGIQDTNSKKQ | 254. CGIQDTNSKKQS | 255. GIQDTNSKKQSD | 256. IQDTNSKKQSDT |
257. QDTNSKKQSDTH | 258. DTNSKKQSDTHL | 259. TNSKKQSDTHLE | 260. NSKKQSDTHLEE |
261. SKKQSDTHLEET | Â | Â | Â |
Application Notes
- Identify high antigenicity epitopes for antibody production & vaccine development
- Locate (auto)antigen epitopes of (auto)antibodies
- Define the best antibody clone against the protein-of-interest
- Perform epitope mutant analysis
- Map B cell epitopes
Service Features
- Small serum sample volume required (2 µl)
- High density (simultaneously analyze hundreds of overlapping peptides)
- High sensitivity
- Large dynamic range
- Suitable for high-throughput assays
- High efficiency and accuracy
- Affordable, quick and simple to use
Kit Components
- RayBio® human PD-L1 protein peptide array
- Blocking Buffer
- Wash Buffer I
- Wash Buffer II
- Biotin-conjugated secondary antibody
- Cy3 equivalent dye conjugated streptavidin
- Array accessories (including slide incubation chamber assembly, gasket, adhesive plastic strips, etc.)
Other Materials Required
- Distilled water
- Small plastic boxes or containers
- Orbital shaker or oscillating rocker
- Pipettors, pipette tips and other common lab consumables
- Aluminum foil
- Laser fluorescence scanner
View Compatible Laser Scanners
Don't have a compatible scanner? RayBiotech now offers FREE scanning service for all RayBio glass slide antibody arrays! Learn More